Echocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis  by Mostafa, Shaimaa A.
The Egyptian Heart Journal (2013) 65, 135–139Egyptian Society of Cardiology
The Egyptian Heart Journal
www.elsevier.com/locate/ehj
www.sciencedirect.comORIGINAL ARTICLEEchocardiographic variables associated with mitral
regurgitation after aortic valve replacement
for aortic valve stenosisShaimaa A. MostafaDepartment of Cardiovascular Medicine, Benha University, EgyptReceived 11 June 2012; accepted 6 September 2012
Available online 23 October 2012E-
Pe
11
htKEYWORDS
Echocardiography;
Mitral regurge;
Aortic stenosis;
Aortic valve replacementmail address: shaimaamustaf
er review under responsibilit
Production an
10-2608 ª 2012 Egyptian So
tp://dx.doi.org/10.1016/j.ehj.2a2011@g
y of Egyp
d hostin
ciety of C
012.09.0Abstract Background: Mitral regurgitation (MR) is frequently associated with aortic stenosis.
Previous reports have shown that coexisting mitral insufﬁciency can regress after aortic valve
replacement (AVR) while others recommend dealing with examination.
Aim: The study aimed to assess the severity of MR before and after aortic valve replacement for
aortic stenosis and to deﬁne the determinants of its postoperative evolution.
Methods: For this purpose, 30 adult patients referred for aortic valve surgery underwent pre- and
1 month postoperative transthoracic echocardiography including 2D, MM, PW, CW and color
Doppler examination.
Results: Postoperative MR improved in 68.4% of the 19 patients (63.3%) who had preoperative
moderate MR (p= 0.002). The effect of the valve size on the postoperative MR was statistically
insigniﬁcant (0.059) but was signiﬁcant on regression of the mass (p= 0.001) and drop in mean
PG (p= 0.04) across AV. Patients with persistent moderate MR after surgery were all in AF
and had signiﬁcantly larger left atrial size (45 ± 26 mm), compared to none and a smaller left atrial
(37 ± 19 mm) in patients in whom MR regressed or disappeared after surgery; respectively,
p< 0.05. The postoperative variables associated with moderate MR were peak PG across AV
(29.4 ± 5.1 vs 38.0 ± 5.7 p= 0.004), mean PG (15.04 ± 4.4 vs 22.8 ± 5.8 p= 0.009) and LVMI
(124.7 ± 19.3 vs 147.2 ± 31.6 p= 0.065).
Conclusion: Preoperative predictors of residual postoperative MR were large LA and AF while the
postoperative variables were high peak and mean pressure gradient across the aortic valve and high
LVMI.
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011. Introduction
Mitral regurgitation (MR) frequently co-exists in patients with
aortic stenosis (AS), and is often functional in origin without
demonstrable structural abnormality. Initial chronic pressure
overload occurring in longstanding AS produces concentric
hypertrophy that increases trans-mitral pressure gradient.1g by Elsevier B.V. All rights reserved.
136 S.A. MostafaThis, in turn, can either worsen existing structural MR or pro-
duce MR in the absence of structural abnormality. Progression
to diastolic dysfunction then produces further functional dete-
rioration. MR of varying degrees has been reported in up to
75% of patients undergoing AVR.2
Co-existent mitral regurgitation may adversely inﬂuence
both morbidity and mortality in patients undergoing aortic
valve replacement for severe aortic stenosis. While it is ac-
cepted that concomitant mitral intervention is required in se-
vere, symptomatic mitral regurgitation but in cases of
moderate non-structural MR the surgical decision making is
inﬂuenced by an expectation that there will be a reduction in
MR with relief of the gradient across the aortic valve (AV).3
There is some evidence that regurgitation improvement
may be seen following aortic valve replacement alone, avoiding
the increased risk of double-valve surgery; the exact beneﬁt of
such a conservative approach is, however, yet to be adequately
quantiﬁed.
1.1. Aim of the study
This study aimed to evaluate prospectively the frequency and
degree of MR in patients with severe aortic stenosis and its
evolution after aortic valve replacement.
2. Patients and methods
This was a prospective study which included 18 men and 12
women with a mean age of 60 ± 7 years suffering from severe
Aortic stenosis. All patients were subjected to open heart
surgery and had their Aortic valves replaced by mechanical
prosthesis.bileaﬂet prosthesis (St. Jude Medical; median
diameter, 22 mm; range, 19–25 mm) the selection of the size
based on BSA and the diameter of the aortic root; Patients
with a narrow aortic root (mostly were female) received valve
size 19 or 21 mm, patients with concomitant AR, physically
active or larger BSA and aortic root received valve size 23
or 25 mm.
Patients with severe aortic regurgitation, structural mitral
reguge, unstable hemodynamic state, arrhythmia, and contra-
indication to surgery were excluded. We also excluded patients
who had to undergo mitral valve or mitral annulus surgery or
who needed CABG operation.
Echocardiographic study was performed using a GE Vivid
7 ultrasound apparatus twice for each patient pre and post
operatively including 2D, MM, color and PW, CW Doppler
for evaluation of the severity of aortic and mitral valve disease
and the degree of pulmonary hypertension if present and the
evaluation of the LV function, dimensions and mass.
Severity of aortic stenosis was quantiﬁed by measuring
peak and mean pressure gradients across the aortic valve using
continuous wave Doppler. The aortic valve area was assessed
using the continuity equation.
Left ventricular end-diastolic and end-systolic dimensions,
end-diastolic thickness of the interventricular septum, and pos-
terior LV wall were assessed with M-mode parasternal echo-
cardiography. The Penn formula was used to calculate LV
mass that was indexed to the body surface area.4
LV mass ðPennÞ ¼ 1:04 ð½LVIDDþ PWTDþ IVSTD3
 ½LVIDD3Þ  13; 6g ð4ÞBSA ¼ ðW0:425 H0:725Þ  0:007184
Presence and severity of MR were assessed using color
Doppler ﬂow imaging in apical 4 and 2 chamber views and
in the parasternal long axis view. Mitral regurgitation was con-
sidered mild, moderate, or severe when the regurgitant jet area
was <4 cm2, 4–8 cm2, or >8 cm2, respectively. Left atrium
dimensions were measured in the PLX and apical 4 chamber
views. In case of AF average of 7–10 cycles was measured
for the dimension, mean and peak PG and degree of MR.
Postoperatively, the same transthoracic parameter mea-
surements were performed within month after aortic valve
replacement using the same methods.
2.1. Statistical analysis
The collected data were analyzed using SPSS 16 software,
quantitative variables were expressed as mean ± standard
deviation (SD), using Wilcoxon test for comparing paired data
and Mann Whitney U test for comparing independent sam-
ples. Categorical data were presented as number and percent-
ages, using Mc Nemar test for comparing paired data and
Fisher’s exact test (instead of the conventional chi square be-
cause of the small cell frequency,<5) for comparing indepen-
dent groups, 2 tailed P value was calculated and it was
considered signiﬁcant if 60.05.
3. Results
Aortic stenosis was of bicuspid etiology in 2 cases and was
degenerative in 28. A mild to moderate aortic regurgitation
was associated in 20 patients preoperatively. The pre- and
postoperative characteristics of the patients are listed in
Table 1.
Postoperative MR improved in 68.4% of the 19 patients
(63.3%) who had preoperative moderate MR (p 0.002).
Patients showing persistence of moderate MR after surgery
were all in AF compared to none of the patients in whom mod-
erate MR decreased or disappeared after AVR (P< 0.05).
Their former had a signiﬁcantly larger left atrial size, com-
pared to that measured in the latter group of patients
(45 ± 26 mm vs. 37 ± 19; P< 0.05). On the other hand, per-
sistence of moderate MR was associated with higher peak PG
over AV (28 ± 15 vs 35 ± 11 mmHg; P> 0.05), higher mean
PG over AV (15 ± 7 mmHg vs 25 ± 5 mmHg; P= 0.049),
higher PASP (27 ± 2 vs. 55 ± 5 mmHg; P> 0.05) and higher
LVMI (145 ± 12 vs 170 ± 8; P= 0.005), compared to pa-
tients in whom MR decreased or disappeared after surgery;
respectively. The systolic function was within normal in pa-
tients in both groups (60 ± 2 vs 58 ± 4); P> 0.05 Table 2.
The effect of the valve size on the postoperative MR was
statistically insigniﬁcant (0.059) but was signiﬁcant on regres-
sion of the mass (p= 0.001) and drop in mean PG
(p= 0.04) across AV Table 3.
Postoperative associations of persistent MR were higher
peak PG (p= 0.004), mean PG (p= 0.009) and LVMI
(p= 0.065) Table 4.
4. Discussion
The prevalence of concomitant moderate mitral regurgitation
(MR) in patients with severe aortic stenosis presenting for
Table 2 Predictors of persistence of moderate MR after aortic valve replacement.
Patient criteria Improved MR (n= 13) No improvement in MR (n= 6) P value
AV Peak PG 28 ± 15 mmHg 35 ± 11 mmHg >0.05
AV Mean PG 15 ± 7 mmHg 25 ± 5 mmHg 0.049
PASP 27 ± 2 mmHg 55 ± 5 mmHg >0.05
LA size 37 ± 19 mm 45 ± 26 mm <0.05
AF 0 6 <0.05
LVMI 145 ± 12 170 ± 8 0.005
EF% 60 ± 2 58 ± 4 >0.05
Table 1 The pre- and postoperative characteristics of the patients.
Echocardiography Preoperative (N= 30) Postoperative (N= 30) P Value
Mean ± SD Mean ± SD
Peak PG across AV (mmHg) 82.6 ± 9.2 31.1 ± 6.2 <0.001
Mean PG across AV (mmHg) 55.3 ± 5.8 16.6 ± 5.6 <0.001
PASP (mmHg) 54.5 ± 5.7 28.3 ± 3.6 <0.001
LVIDd (mm) 52.1 ± 3.7 50.9 ± 4.8 0.198
LVIDs (mm) 32.5 ± 3.03 30.9 ± 2.24 0.043
PWTd (mm) 13.3 ± 0.86 12.4 ± 0.71 <0.001
SWTd 13.1 ± 0.94 11.8 ± 0.78 <0.001
LA size 4.42 ± 0.56 4.38 ± 0.64 0.63
LVEF% 62.9 ± 7.2 63.3 ± 7.3 0.66
LV mass (g/m2) 187.3 ± 33.6 129.2 ± 23.5 <0.001
Degree of MR No. % No. %
No or mild MR 11/30 36.7 24/30 80.0 0.002
Moderate MR 19/30 63.3 6/30 20.0
Atrial ﬁbrillation 6/30 23.3 7/30 20.0 1.0
Table 4 Postoperative variables associated with postoperative MR.
Postoperative variables Postoperative MR P value
No or mild MR (n= 24) Moderate MR (n= 6)
Mean ± SD Mean ± SD
Post Peak (mmHg) 29.4 ± 5.1 38.0 ± 5.7 0.004
Post Mean (mmHg) 15.04 ± 4.4 22.8 ± 5.8 0.009
Post mass 124.7 ± 19.3 147.2 ± 31.6 0.065
Table 3 Relation between aortic valve size and pressure gradient, LVMI and degree of MR.
Size 19 (n= 12) Size 21 (n= 13) Size 23 (n= 4) Size 25 (n= 1) P value
BSA (m2) 1.64 ± 0.12 1.74 ± 0.20 1.82 ± 0.17 1.91 ± 0.17
Postoperative mean PG 20 ± 6.8 18 ± 6.0 16 ± 5.7 12 ± 6.7 0.04
Postoperative LVMI 130 ± 17.6 124 ± 44.4 113 ± 27.1 119 ± 50.8 0.001
Postoperative MR (n= 2) 16% (n= 3)15.4% (n= 1)25% 0 0.059
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to improve after aortic valve replacement (AVR). However, a
certain subset of MR may stay the same or even worsen and
may lead to poor functional outcomes.5
Patients with myxomatous or rheumatic mitral valves are of-
ten surgically repaired or replaced at the same setting as AVR as
they are not likely to improve. While mild concomitant func-
tional MR during AVR is left alone, severe MR is addressed
during the same surgery. However, in patients with moderate
MR, the management is unclear. The risk beneﬁt ratio needsto be addressed with issues of double valve surgery mortality
(unadjusted mortality is twice as high in MVR and AVR com-
pared toAVRalone) versus the poor functional outcomes in un-
treated persistent MR and the potential for morbidity and
mortality associated with a possible reoperation in the future.6
Some believe that additional MV surgery is not necessary in
patients with preserved left ventricular function and without
organic MV disease.7
Others found that despite reverse remodeling, concomitant
moderate–severe mitral regurgitation adversely affects both
138 S.A. Mostafaearly and late mortality following aortic valve replacement.
Concomitant mitral intervention should therefore be consid-
ered in the presence of moderate mitral regurgitation, indepen-
dent of the etiology.8
As regard to the performed systematic literature review in-
cluded 17 studies incorporating 3053 patients undergoing aor-
tic valve replacement for aortic stenosis with co-existing mitral
regurgitation, who concluded that despite reverse remodeling,
concomitant moderate mitral regurgitation adversely affects
both early and late mortality following aortic valve replace-
ment.9 It seems reasonable to look for the pre and postopera-
tive variables associated with evolution of MR.
In the present study moderate MR improved signiﬁcantly
(68%) after AVR, the effect of the valve size on the postoper-
ative MR was statistically insigniﬁcant but was signiﬁcant on
regression of the mass and drop in mean PG across AV. Pre
LA and AF were signiﬁcant predictors of postoperative resid-
ual MR and the postoperative associations of persistent MR
were higher peak, mean PG and LVMI.
These results are in agreement with a study on 227 patients
with stenotic AV disease without structural mitral valve dis-
ease underwent AVR, MR severity improved in 66% of pa-
tients. Predictor of lower postoperative MR was the small
left atrial size (p= 0.03), and found that prosthetic valve type
or size was not an independent predictor of postoperative
MR.10
Also Durst et al., 2011 found that after isolated AVR a
trend toward improvement in MR was observed. Left ventric-
ular dysfunction, left atrial enlargement, and atrial ﬁbrillation
were associated with progression of MR after AVR.11
Emily et al., 2008 analyzed the characteristics that were
independently associated with changes in MR after AVR
and found that arial ﬁbrillation is a predictor of residual
MR and referred this to its relationship with left atrial size
(p= 0.02), CHF (p= 0.001), and age (p= 0.001) and con-
cluded that patients with atrial ﬁbrillation are less likely to
see improvement in MR. This effect is accounted by the pres-
ence of correlate variables.12
Considering its low grade, MR alone could not induce left
atrium dilation nor increase in tricuspid regurgitation velocity
that we observed. These changes could be the result of the dia-
stolic impairment induced by LV hypertrophy.
After aortic valve replacement, LV mass and parietal
thickness signiﬁcantly decreased. Left ventricular remodeling
results from changes in loading conditions such as reduction
of pressure gradients between aorta and left ventricle, Shahab
2009 who found that patient–prosthesis mismatch (deﬁned as
the generation of a high transvalvular gradient through a
normally functioning prosthetic valve) results in an increased
LV work, which in turn inﬂuenced the regression of LV
hypertrophy the latter is a strong independent risk factor
for mortality as well as a major determinant of systolic and
diastolic function and the persistence or even worsening of
the degree of MR.13
And also Calvin et al., 2009 found that functional MR im-
proves in approximately 75% of patients undergoing AVR for
AS and the independent predictors of immediate improvement
included smaller LA lesser degree of TR and lower PASP and
explained that these factors reﬂect more physiologically sub-
stantial MR, may be less likely to improve with AVR alone.14
Yoshikawa et al. 2009 studied the negative effects caused by
residual obstruction of the left ventricular outﬂow tract on 221patients who underwent isolated aortic valve replacement with
a 23-mm or smaller St. Jude Medical valve. The long-term re-
sults demonstrated that a small St. Jude Medical valve can be
advantageously used in small body size, also emphasize that it
is not prosthesis size per se that matters but rather the relation
between body size and prosthesis size. And to keep in mind
that sometimes there is a discrepancy between aortic root
diameter and body surface area.15
4.1. Limitation
The study focused to the evolution of MR early after AVR
(within 1 month) but didn’t follow the effect of MR on patient
survival or the need for reoperation for MR and also we have
to admit that our small sample size did not allow us to evaluate
the possible roles of preoperative enlarged Left atrium or AF
as independent predictors for the persistence of moderate
MR after AVR.5. Conclusion
So we can conclude that patients with functional moderate
MR should be subjected to careful selection of the prosthesis
to avoid patient-prosthesis mismatch and to consider concom-
itant MV repair or replacement in case of LA dilation and AF
or least obtaining these values for evaluation of the degree of
MR intraoperatively in guiding the surgical management.References
1. Sophiet Damienm Pierre N, Fre´de´rict Bertrand J, Bernard B.
Factors determining early improvement in mitral regurgitation
after aortic valve replacement for aortic valve stenosis: a
transthoracic and transesophageal prospective study. Clin Cardiol
2003;26:127–31.
2. Marc R, Joel Pr, Alexander K, Ian GB, Thierry G. Natural history
and predictors of outcome in patients with concomitant functional
mitral regurgitation at the time of aortic valve replacement.
Circulation 2006;114:1–541.
3. Leanne H, Srdjan S, Omar A, Antonios K, Emaddin K, Thanos A.
Aortic valve replacement for aortic stenosis in patients with
concomitant mitral regurgitation: should the mitral valve be dealt
with? Eur J Cardiothorac Surg 2011;40:1087–96.
4. Devereux B. Detection of left ventricular hypertrophy by M-mode
echocardiography anatomic validation, standardization, and com-
parison to other methods. Hypertension 1987;9:II9–II26.
5. Matsumura Y, Gillinov AM, Toyono M, Oe H, Yamano T,
Takasaki K, et al. Persistent functional mitral regurgitation after
aortic valve replacement in patients with aortic valve stenosis. Am
J Cardiol 2010;106(5):701–6.
6. Matsumura Y. Echocardiographic predictors for persistent func-
tional mitral regurgitation after aortic valve replacement in
patients with aortic valve stenosis. Am J Cardiol 2012;106:701–6.
7. Goland S, Loutaty G, Arditi A. Improvement in mitral regurgi-
tation after aortic valve replacement. Med Assoc J Jan
2003;5(1):12–4.
8. Zoghbi W, Enriquez S, Grayburn P, Kraft C, Levine R,
Nihoyannopoulos P, et al. Recommendations for evaluation of
the severity of native valvular regurgitation with twodimensional
and doppler echocardiography. J Am Soc Echocardiogr
2003;16:777–802.
9. Byu S, Young N, Kyung J, Sak L. Fate of functional mitral
regurgitation and predictors of persistent mitral regurgitation after
isolated aortic valve replacement. Ann Thorac Surg 2011;92:82–7.
Echocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis 13910. Eynden F, Bouchard D, El-Hamamsy I. Effect of aortic valve
replacement for aortic stenosis on severity of mitralregurgitation.
Ann Thorac Surg 2007;83:1279–84.
11. Durst R, Avelar E, McCarty D, Poh KK, Friera LF, et al.
Outcome and improvement predictors of mitral regurgitation after
transcatheter aortic valve implantation. J Heart Valve Dis.
2011;20(3):272–81.
12. Emily C, Louis -M, Avery Edwin G, Picard, Gus J, Arvind K.
Changes in mitral regurgitation after replacement of the stenotic
aortic valve. Ann Thorac Surg 2008;86:56–63.13. Shahab N. The inﬂuence of prosthesis-patient mismatch for left
ventricular remodeling, cardiac function and survival. J Cardio-
thorac Vasc Anesth 2009;23:161–5.
14. Calvin K, Rakesh M, Zhuo Li, Orszulak Thomas A, M Richard C,
et al. Management of moderate functional mitral regurgitation at
the time of aortic valve replacement: is concomitant mitral valve
repair necessary? J Thorac Cardiovasc Surg 2009;137(3):3.
15. Yoshikawa K, Fukunaga S, Arinaga K, Hori H, Nakamura E,
Ueda T, et al. Long-term results of aortic valve replacement with
a small St. Jude medical valve. Ann thorac surg 2008;85(4):1303–8.
